Trial intelligence / Profile preview

Fluoxetine in Preschool Children with Autism

NCT00183339Phase 2Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Jul 2005
Primary completion
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluoxetine in Autism Spectrum Disorder (ASD), sponsored by University of North Carolina at Chapel Hill. Started Jul 2005; status: completed.

02

Drugs

fluoxetine
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT00183339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00183339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call